首页>
外国专利>
Oral formulation of blueberry extract as an adjunct to maintaining human anterior corneal health
Oral formulation of blueberry extract as an adjunct to maintaining human anterior corneal health
展开▼
机译:蓝莓提取物作为维持人类前角膜健康的辅助口服制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to dietary supplement formulations for human oral intake of blueberry extracts, fish oils (omega 3 and omega 6), recombinant human lactoferrin, vitamin A and vitamin E. The present invention belongs to the field of ophthalmology and has been developed as an auxiliary agent for maintaining the health of the precorneal tear film and the surface of the eyeball. This formulation contains a naturally occurring extract (Vaccinium myrtillus L) with anti-oxidant and anti-inflammatory properties and also provides omega-6 eicosapentaenoic acid (EPA) and omega-3 docosahexaenoic acid (Omega 3 docosahexaenoic acid) from fish oil. DHA) is also used, and lactoferrin, vitamin A and vitamin E have antibacterial and anti-inflammatory effects, and thus improve the quality of tears together with these compounds. This formulation is designed as an adjunct to maintain the health of the precorneal tear film. No formulation for oral administration of blueberry extract in combination with vitamin A, vitamin E and fish oil (eicosapentaenoic acid and docosahexaenoic acid) together with lactoferrin has been found in the prior art, and this formulation is used in precorneal tear film. There is also no use of this formulation as an adjuvant to maintain the health of the membrane and / or eye surface. [Selection diagram] None
展开▼